Cover Image
市場調查報告書

額顳葉型失智症 (FTD):主要9個國家的市場預測 (2015-2025年)

Frontotemporal Lobe Dementia in 9 Major Markets 2015-2025

出版商 Black Swan Analysis 商品編碼 346457
出版日期 內容資訊 英文 38 Pages
訂單完成後即時交付
價格
Back to Top
額顳葉型失智症 (FTD):主要9個國家的市場預測 (2015-2025年) Frontotemporal Lobe Dementia in 9 Major Markets 2015-2025
出版日期: 2015年12月09日 內容資訊: 英文 38 Pages
簡介

所謂額顳葉型失智症 (FTD) ,是額葉、顳葉的變性及引起萎縮的進行性退化性疾病,是65歲以下發生癡呆的原因,是第二常見的神經退化性疾病。

本報告提供全球主要9個國家(美國、法國、德國、義大利、西班牙、英國、巴西、日本、印度) 的額顳葉型失智症 (FTD) 的發病相關情況調查、疾病概要和目前的患病人數、性別/各年代 (5歲區隔) 的詳細情況、各地區/各民族趨勢、風險要素、疾病診斷與預後、主要的症狀和併發症等彙整資料。

目錄

  • 圖表
  • 簡介
  • 疾病的原因
  • 風險要素與預防法
  • 疾病診斷
  • 各地區、各民族的差異
  • 疾病的預後和臨床過程
  • 疾病相關的主要並存症/特徵
  • 患者數的定量化的方法
  • 額顳葉型失智症 (FTD) 的主要特徵
    • FTD臨床症候群的分類
    • FTD的類型:各蛋白質變異
    • FTD患者的神經系統疾病
    • FTD患者的行動障礙
  • 本文中的簡稱一覽
  • Black Swan的其他出版刊物
  • Black Swan Analysis的患者為基礎的線上資料庫
  • 患者為基礎的服務
  • 線上價格趨勢資料、平台
  • 參考文件
  • 附錄

圖表一覽

目錄
Product Code: FTDA0011215

Frontotemporal lobe dementia (FTD) is a progressive degenerative disorder characterised by degeneration and atrophy of the frontal and anterior temporal lobes. It is the second most common neurodegenerative disorder resulting in dementia in the under 65's and a limited life expectancy. This report provides the current prevalent population for FTD across 9 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan and India) split by gender and 5-year age cohort. Along with the current prevalence, the report provides a breakdown of the sub-group classifications of the disease, disease origin and tau protein mutations in the FTD patient population. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of FTD have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for FTD include:

  • Dementia and cognitive disorders
  • Speech and semantic problems
  • Limb/muscle weakness and rigidity
  • Behavioural disorders
  • Appetite changes

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global FTD's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of FTD and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on FTD's prevalent population.
  • Examination of the prevalence for different causative protein mutations in FTD.
  • Identify sub-populations within FTD which require treatment.
  • Gain an understanding of the specific markets that have the largest number of FTD patients.

Coverage

  • US
  • UK
  • FR
  • DE
  • IT
  • ES
  • JP
  • BR
  • IN

Table of Contents

  • List of Tables and Figures
  • Introduction
  • Cause of the Disease
  • Risk Factors & Prevention
  • Diagnosis of the Disease
  • Variation by Geography/Ethnicity
  • Disease Prognosis & Clinical Course
  • Key Co-morbid Conditions /Features Associated with the Disease
  • Methodology for Quantification of Patient Numbers
  • Top-Line Prevalence for Frontotemporal Lobe Dementia
  • Main Features of Frontotemporal Lobe Dementia
    • FTD Clinical Syndrome Classification
    • Type of FTD by Protein Mutation
    • Neurological Diseases Associated with FTD Patients
    • Behavioural Disorders in FTD Patients
  • Abbreviations used in the Report
  • Other Black Swan Analysis Publications
  • Black Swan Analysis Online Patient-Based Databases
  • Patient-Based Offering
  • Online Pricing Data and Platforms
  • References
  • Appendix

List of Tables

  • Prevalence of FTD, total (000s)
  • Prevalence of FTD, males (000s)
  • Prevalence of FTD, females (000s)
  • Sub-group classification of FTD, total (000s)
  • Origin of FTD in patients, total (000s)
  • Tau mutation type in FTD patients, total (000s)
  • Alzheimer's disease in FTD patients, total (000s)
  • ALS in FTD patients, total (000s)
  • Disinhibition in FTD patients, total (000s)
  • Agitation in FTD patients, total (000s)
  • Anxiety in FTD patients, total (000s)
  • Apathy in FTD patients, total (000s)
  • Abbreviations and acronyms used in the report
  • USA Prevalence of FTD by 5-yr age cohort, males (000s)
  • USA Prevalence of FTD by 5-yr age cohort, females (000s)
  • France Prevalence of FTD by 5-yr age cohort, males (000s)
  • France Prevalence of FTD by 5-yr age cohort, females (000s)
  • Germany Prevalence of FTD by 5-yr age cohort, males (000s)
  • Germany Prevalence of FTD by 5-yr age cohort, females (000s)
  • Italy Prevalence of FTD by 5-yr age cohort, males (000s)
  • Italy Prevalence of FTD by 5-yr age cohort, females (000s)
  • Spain Prevalence of FTD by 5-yr age cohort, males (000s)
  • Spain Prevalence of FTD by 5-yr age cohort, females (000s)
  • United Kingdom Prevalence of FTD by 5-yr age cohort, males (000s)
  • United Kingdom Prevalence of FTD by 5-yr age cohort, females (000s)
  • Brazil Prevalence of FTD by 5-yr age cohort, males (000s)
  • Brazil Prevalence of FTD by 5-yr age cohort, females (000s)
  • Japan Prevalence of FTD by 5-yr age cohort, males (000s)
  • Japan Prevalence of FTD by 5-yr age cohort, females (000s)
  • India Prevalence of FTD by 5-yr age cohort, males (000s)
  • India Prevalence of FTD by 5-yr age cohort, females (000s)
Back to Top